MEDICAL BIO WARFARE DEFENSE PLAN 8 APR 91

File: 970101_sep96_decls1_0151.txt
Page: 0151
Total Pages: 194

Subject: MEDICAL BIO WARFARE DEFENSE PLAN  8 APR 91                      

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003202

Folder Title: MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN                                                   

Document Number:          2

Folder Seq  #:         25





                                            lQr.r%nrT
                                           %JLUU= UNCLASSIFIED


                Storm the modified series is given at                   significant
         levels Of antibody and a          ve l@             anthrax can be expected@


                   (2) (U) After all United States Fb@ have been vaccinated with
         two doses, each SM will @ve a third vaocimticn dose at least two
         after the        dose to                    on.

              b. -ft Botulum =M. Botul@ va@ (tcdcoid)                     d be given in

         protective 1       of antibodies establi@
         dose. Booster dose is given at one year              as nmW in the ACR.

         3-3. (U) Dia=mis            on,

              a.  @ Anthrax,

                   (1) (U) Signs and           are mal@, fatigue, muscle pain, mild
         fever,            ve @ with progress=n to dyspnea and shock; widened
                     on chest X-ray is character@c.

                   (2) W            Blood (Ala) Test, @ AB test is to provide a
         prel        detection test to enable medical             to support          ve
         clinical diagnosis of anthrax. Cmfirmaticn by alternative laboratory tests
         is             see Para 2-3. AB t@ is also called the
                                        @irug           it is calloc

               AB               be refr     ted, but stability          has        it to
         be stable for one year at rom          ture and at l@ six           at
                tures of 450 C (1130 F). Irxiicators for ure of the AB test are as
         follows:

                        (a) (U) Cl      of EM with respiratory
         (febrile respimtory                   onset/outbreak in the @ area of
         cparaticrw3 at the      time, rapid progression to str@ and respiratory
              ficiency, @                 on chest X-ray with wwor without
         effusicn without            infiltrates).

(b)            or         anthrax @iratory             risk or
         cases in ACR.

                        (c) (U)                    c respiratory deaths, acute
         respiratory failure or       ficiency

                        (d) (U) Unexp       aninal i3.lness and death.






                                                3-2

                                          UNCLASSIFIED
                                           cor.13rllr.z_
                                            OLtiRL 1

Document 194 f:/Week-36/BX003202/MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN/medical bio warfare defense plan 8 apr 91:1224960931152
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003202
Unit = OTSG
Parent Organization = HSC
Folder Title = MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN
Folder Seq # = 25
Subject = MEDICAL BIO WARFARE DEFENSE PLAN 8 APR 91
Document Seq # = 2
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 24-DEC-1996